Adds seasoned Wealth Advisors, Michael Schiavello and Billy Takos, and team of 12 experienced wealth advisors NEW YORK, March 5, 2024 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has further expanded its wealth management practice to include a team of 12 seasoned wealth advisors led by Mr. Michael Schiavello and Mr. Billy Takos.  Mr. Schiavello and Mr. Billy Takos will serve as Managing Directors and Co-Heads of P ...

Adds wealth management talent in support of 'growth and development' strategy NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, is growing its wealth management team with the addition of senior wealth management executive Mr. Raymond Guarini. Mr. Kyle Wool, CEO of Dominari Securities LLC, commented, "A principal component of our 'growth and development' strategy is hiring and retaining wealth ma ...

NEW YORK, Feb. 15, 2024 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, acted as lead underwriter to Unusual Machines (NYSE American: UMAC), an emerging leader in first-person view (FPV) drone technology, in an initial public offering ("Offering") of 1,250,000 shares of common stock at a public offering price of $4.00 per share for gross proceeds of $5.0 million before deducting underwriting discounts and other relat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number 001-41845 DOMINARI HOLDINGS INC. (Exact name of registrant as specified in its charter) (State or other j ...

Revenue and Loss - For the three months ended June 30, 2023, the company recognized approximately $0.07 million in revenue, primarily from underwriting revenue earned by Dominari Securities[100]. - The company incurred a loss from operations of approximately $9.0 million for the three months ended June 30, 2023, compared to a loss of $2.3 million for the same period in 2022[100]. - For the six months ended June 30, 2023, the company recognized approximately $0.07 million in revenue and incurred a loss from operations of approximately $12.8 million, compared to a loss of $6.1 million in 2022[102]. Expenses - General and administrative expenses increased by approximately $6.8 million, driven by professional fees and increased compensation expenses due to growing operations[101]. - The company is transitioning away from the biotechnology industry into financial services, resulting in a nearly 100% decrease in research and development expenses[101]. Cash Flow - Cash used in operating activities for the six months ended June 30, 2023, was approximately $13.9 million, primarily due to a net loss of approximately $11.7 million[106]. - Net cash used in investing activities for the six months ended June 30, 2023, was approximately $14.7 million, resulting from the purchase of marketable securities of approximately $34.0 million[107]. - Cash used in financing activities for the six months ended June 30, 2023, was approximately $0.9 million, reflecting the cost for the purchase of treasury stock[108]. Financial Position - The company's working capital amounted to approximately $35.7 million as of June 30, 2023, with expectations that cash and cash equivalents will be sufficient for at least the next 12 months[103]. - The company reported a gain of approximately $0.4 million in marketable securities for the three months ended June 30, 2023, a decrease of approximately $2.6 million in losses compared to the prior year[101].

Financial Performance - Net loss attributable to common shareholders for the three months ended March 31, 2023, was $3,762 thousand, compared to a net loss of $6,544 thousand for the same period in 2022, indicating an improvement of approximately 42.2%[12] - Basic and diluted net loss per share improved from $(1.25) in Q1 2022 to $(0.71) in Q1 2023, reflecting a reduction of 43.2%[12] - The net loss for the three months ended March 31, 2023, was $3.762 million, compared to a net loss of $3.535 million for the same period in 2022[21] - For the three months ended March 31, 2023, the company recorded a realized loss of $56,000 and an unrealized loss of $130,000 on marketable securities, with total losses amounting to $65,000[51] - The company reported a net loss of approximately $3.8 million for the three months ended March 31, 2023[128] Cash and Liquidity - Cash and cash equivalents significantly decreased from $33,174 thousand to $9,533 thousand, representing a decline of about 71.3%[10] - The cash and cash equivalents at the end of the period were $9.533 million, down from $70.639 million at the end of the same period in 2022[21] - The company has adequate cash to fund its operations for at least the next twelve months[27] - As of March 31, 2023, the company's working capital was approximately $43.8 million[127] - For the three months ended March 31, 2023, net cash used in operating activities was approximately $4.0 million, compared to $3.8 million for the same period in 2022[128] Expenses - General and administrative expenses rose to $3,833 thousand in Q1 2023, up from $1,787 thousand in Q1 2022, marking an increase of about 114.0%[12] - The company reported total operating expenses of $3,834 thousand for Q1 2023, slightly up from $3,803 thousand in Q1 2022, an increase of approximately 0.8%[12] - The company incurred approximately $2.0 million in increased general and administrative expenses, driven by professional fees and increased compensation expenses[126] - The company recognized other income of approximately $0.07 million for the three months ended March 31, 2023, compared to $0.3 million in the same period in 2022, primarily due to volatility in investment valuations[125] Assets and Liabilities - Total current assets decreased from $50,656 thousand as of December 31, 2022, to $44,771 thousand as of March 31, 2023, a decline of approximately 11.7%[10] - Total liabilities increased from $2,469 thousand as of December 31, 2022, to $5,083 thousand as of March 31, 2023, an increase of approximately 105.5%[10] - Total stockholders' equity decreased from $73,767 thousand as of December 31, 2022, to $69,071 thousand as of March 31, 2023, a decline of about 6.4%[10] Investments - The investment in Kerna Health Inc. was valued at $4.9 million as of March 31, 2023, with no change in value since December 31, 2022[54] - The investment in Tevva Motors was valued at approximately $2.8 million as of March 31, 2023, reflecting no change in value since December 31, 2022[61] - The total value of long-term investments remained unchanged at $23.103 million as of March 31, 2023[54] - The investment in Epic Games was valued at $3.5 million as of March 31, 2023, with no unrealized gain or loss recorded during the period[68] - The investment in SpaceX was valued at approximately $3.7 million as of March 31, 2023, reflecting an unrealized gain of approximately $0.6 million[71] Acquisitions - The company acquired all assets and liabilities of Fieldpoint Private Securities, LLC (FPS) for approximately $3.4 million, with a net cash paid of $1.149 million[21][44] - The FPS acquisition was completed on March 27, 2023, following the approval of the change of ownership by FINRA[44] - The total assets acquired from FPS amounted to $3.784 million, while total liabilities assumed were $360,000, resulting in total net assets of $3.424 million from the acquisition[49] - The company incurred approximately $0.3 million in transaction costs related to the FPS acquisition, which are included in general and administrative expenses[47] Shareholder Actions - The company repurchased 236,630 shares at a cost of approximately $0.9 million, averaging $3.97 per share, under its Share Buyback Program during the three months ended March 31, 2023[102] - The company retired 644,499 shares of treasury stock with an original cost of approximately $3.8 million on March 6, 2023[103] Strategic Focus - Dominari Holdings Inc. continues to focus on shifting its primary operating focus from biotechnology to fintech and financial services[23] - The company is winding down its historical pipeline of biotechnology assets while exploring opportunities in high-growth industries through its subsidiary Aikido Labs[24] - The company did not provide proforma disclosures for the FPS acquisition as it did not significantly impact financial results[50] Internal Controls - The company has not made any changes to its internal control over financial reporting that materially affected its effectiveness during the quarter ended March 31, 2023[136] - The company concluded that its internal control over financial reporting was effective as of March 31, 2023[142]

Part I [Business](index=4&type=section&id=Item%201.%20Business) Dominari Holdings Inc. transitioned from biotechnology to financial services, acquiring a broker-dealer to offer comprehensive financial services - The company shifted its primary focus from biotechnology to financial services in the second half of **2022** to enhance shareholder value[15](index=15&type=chunk) - On **March 27, 2023**, the company completed the acquisition of a registered broker-dealer, to be renamed Dominari Securities, LLC[13](index=13&type=chunk)[16](index=16&type=chunk) - Dominari Securities will offer a broad range of services, including wealth management, asset management, investment banking, and sales and trading[17](index=17&type=chunk)[20](index=20&type=chunk)[25](index=25&type=chunk)[30](index=30&type=chunk) - The company is in the process of winding down its historical biotechnology assets[14](index=14&type=chunk) - As of **December 31, 2022**, the company had **7 full-time and 1 part-time employees**[45](index=45&type=chunk) [Risk Factors](index=10&type=section&id=Item%201a.%20Risk%20Factors) The company faces significant risks from its limited financial services operating history, ongoing losses, internal control weaknesses, market volatility, and extensive regulation - The company has a limited operating history in its new financial services business, making it difficult to evaluate its prospects[47](index=47&type=chunk) Recent Financial Performance | Metric | Value (as of Dec 31, 2022) | | :--- | :--- | | Net Loss | $22.1 million | | Accumulated Deficit | $185.9 million | - As of **December 31, 2022**, management concluded that internal controls over financial reporting were not effective due to a lack of segregation of duties[52](index=52&type=chunk) - The business is highly dependent on market and economic conditions, impacting fees, transaction volume, and trading revenues[53](index=53&type=chunk)[56](index=56&type=chunk) - The company faces intense competition for qualified employees, and the loss of key personnel could harm the business[59](index=59&type=chunk)[60](index=60&type=chunk) - The financial services industry is subject to extensive regulation by the SEC, FINRA, and state regulators, with potential for significant penalties for non-compliance[96](index=96&type=chunk)[97](index=97&type=chunk)[99](index=99&type=chunk) - The company's common stock is at risk of being delisted from The Nasdaq Capital Market if it fails to meet continued listing standards[108](index=108&type=chunk)[111](index=111&type=chunk) [Unresolved Staff Comments](index=21&type=section&id=Item%201b.%20Unresolved%20Staff%20Comments) As a smaller reporting company, Dominari Holdings Inc. is not required to provide information for this item - The company is not required to provide this information as it qualifies as a smaller reporting company[116](index=116&type=chunk) [Properties](index=21&type=section&id=Item%202.%20Properties) The company leases office space in New York, NY, which is considered adequate for current operational needs - The company leases offices in New York, New York, considered sufficient for current needs[117](index=117&type=chunk) [Legal Proceedings](index=21&type=section&id=Item%203.%20Legal%20Proceedings) The company is not aware of any material, active, or pending legal proceedings, aside from ordinary routine litigation - There are no known material, active, or pending legal proceedings against the company, aside from ordinary routine litigation[118](index=118&type=chunk) [Mine Safety Disclosures](index=21&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This item is not applicable to the company - This section is not applicable[119](index=119&type=chunk) Part II [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](index=22&type=section&id=Item%205.%20Market%20for%20Registrant's%20Common%20Equity%2C%20Related%20Stockholder%20Matters%20and%20Issuer%20Purchases%20of%20Equity%20Securities) The company's common stock trades on Nasdaq, with no cash dividends paid, and details provided on share repurchases and equity compensation plans - The company's common stock trades on the Nasdaq Capital Market under the symbol **"DOMH"**, with **4,840,597 shares outstanding** as of **March 20, 2023**[5](index=5&type=chunk)[122](index=122&type=chunk)[123](index=123&type=chunk) - The company has never paid cash dividends and does not plan to in the foreseeable future[124](index=124&type=chunk) Share Repurchases - Q4 2022 | Period | Total Number of Shares Purchased | Average Price Paid Per Share | Value Remaining for Purchase (in thousands) | | :--- | :--- | :--- | :--- | | Oct 2022 | - | - | $2,000 | | Nov 2022 | - | - | $2,000 | | Dec 2022 | 18,200 | $3.1563 | $1,942 | Equity Compensation Plan Information (as of Dec 31, 2022) | Plan Category | Securities to be issued upon exercise | Weighted average exercise price | Securities remaining for future issuance | | :--- | :--- | :--- | :--- | | Approved by security holders | 479,654 | $32.35 | 4,555,144 | [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=23&type=section&id=Item%207.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Dominari shifted to financial services in 2022, reporting a **$22.1 million net loss** due to transition costs and investment losses, with **$48.9 million working capital** for future operations Financial Results Comparison (Fiscal Years) | Metric | 2022 | 2021 | | :--- | :--- | :--- | | Loss from Operations | $(14.4) million | $(9.4) million | | Other (Expense) Income | $(7.8) million | $2.3 million | | Net Loss | $(22.1) million | $(7.2) million | | Net Loss per Share | $(4.91) | $(1.48) | - The **$5.0 million increase** in loss from operations was primarily due to a **$4.0 million increase in G&A expenses**, including **$1.5 million in stock grants**, **$1.5 million in bonuses**, and **$1.6 million in advisory fees** for the business transition[139](index=139&type=chunk) - Other expenses of **$7.8 million in 2022** were mainly due to a **$6.0 million loss on marketable securities** and a **$2.6 million loss on the change in fair value of investments**[139](index=139&type=chunk) Cash Flow Summary (Fiscal Years, $ in millions) | Cash Flow Category | 2022 | 2021 | | :--- | :--- | :--- | | Net Cash Used in Operating Activities | $(10.6) | $(6.6) | | Net Cash Used in Investing Activities | $(14.6) | $(8.9) | | Net Cash (Used in) Provided by Financing Activities | $(7.2) | $78.3 | - The company had working capital of approximately **$48.9 million** as of **December 31, 2022**, and believes it has adequate cash to fund operations for at least the next twelve months[140](index=140&type=chunk)[188](index=188&type=chunk) [Quantitative and Qualitative Disclosures about Market Risk](index=27&type=section&id=Item%207a.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) As a smaller reporting company, Dominari Holdings Inc. is not required to provide information for this item - The company is not required to provide this information as it qualifies as a smaller reporting company[145](index=145&type=chunk) [Consolidated Financial Statements and Supplemental Data](index=28&type=section&id=Item%208.%20Consolidated%20Financial%20Statements%20and%20Supplemental%20Data) Consolidated financial statements for 2022 and 2021 are presented, showing a **$22.1 million net loss** in 2022, decreased total assets, and the auditor's critical audit matter on investment valuation - The independent auditor, Marcum LLP, identified the valuation of investments and notes receivable as a critical audit matter for the **2022** financial statements[157](index=157&type=chunk) Consolidated Balance Sheet Highlights (as of Dec 31, $ in thousands) | Account | 2022 | 2021 | | :--- | :--- | :--- | | Cash and cash equivalents | $33,174 | $65,562 | | Total current assets | $50,656 | $90,889 | | Total Assets | $76,236 | $102,656 | | Total Liabilities | $2,469 | $1,061 | | Total Stockholders' Equity | $73,767 | $101,595 | Consolidated Statement of Operations Highlights (Year ended Dec 31, $ in thousands) | Account | 2022 | 2021 | | :--- | :--- | :--- | | Total operating expenses | $14,346 | $9,441 | | Loss from operations | $(14,346) | $(9,441) | | Total other (expenses) income | $(7,761) | $2,270 | | Net loss | $(22,107) | $(7,171) | - In **February 2022**, the company issued **$22 million** in Series O and P Redeemable Convertible Preferred Stock, subsequently redeemed for **$23.1 million** in the second quarter of **2022**[309](index=309&type=chunk)[313](index=313&type=chunk) - The company has significant investments in privately-held companies, including Kerna Health, Tevva Motors, Epic Games, and SpaceX, valued at a total of **$23.1 million** as of **December 31, 2022**[236](index=236&type=chunk) Part III [Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](index=70&type=section&id=Item%209.%20Changes%20in%20and%20Disagreements%20with%20Accountants%20on%20Accounting%20and%20Financial%20Disclosure) On **July 5, 2022**, the company changed its independent auditor from WithumSmith+Brown, PC to Marcum LLP, with no reported disagreements - On **July 5, 2022**, the Audit Committee dismissed WithumSmith+Brown, PC and engaged Marcum LLP as the new independent registered public accounting firm[349](index=349&type=chunk)[352](index=352&type=chunk) - There were no disagreements with Withum on any matter of accounting principles, financial statement disclosure, or auditing scope or procedure during its tenure[351](index=351&type=chunk) [Controls and Procedures](index=70&type=section&id=Item%209A.%20Controls%20and%20Procedures) Management concluded that disclosure controls and internal controls over financial reporting were effective as of **December 31, 2022**, with previously identified material weaknesses remediated - Management concluded that disclosure controls and procedures were effective as of **December 31, 2022**[355](index=355&type=chunk) - Material weaknesses identified in **2021** (lack of segregation of duties and inadequate controls) were remediated as of **December 31, 2022**[357](index=357&type=chunk) - Management concluded that internal controls over financial reporting were effective as of **December 31, 2022**, based on the COSO framework[359](index=359&type=chunk) [Directors, Executive Officers and Corporate Governance](index=73&type=section&id=Item%2010.%20Directors%2C%20Executive%20Officers%20and%20Corporate%20Governance) This section lists directors and executive officers, details independent committee compositions, identifies an audit committee financial expert, and notes the ongoing adoption of a code of ethics Key Executive Officers and Directors | Name | Position | | :--- | :--- | | Robert J. Vander Zanden | Director and Chairman of the Board | | Anthony Hayes | Chief Executive Officer and Director | | Carlos Aldavero | President, Dominari Financial Inc. | | Christopher Devall | Vice President of Operations | - The Audit Committee, comprised of independent directors, includes Timothy Ledwick as the designated **'audit committee financial expert'**[383](index=383&type=chunk) - The Compensation Committee consists of independent directors Kyle Wool (Chairman), Robert J. Vander Zanden, and Robert Dudley[386](index=386&type=chunk) - The company is in the process of adopting a written code of business conduct and ethics[389](index=389&type=chunk) [Executive Compensation](index=76&type=section&id=Item%2011.%20Executive%20Compensation) This section details executive compensation for **2022**, including **CEO Anthony Hayes's $1,693,350 total compensation**, employment agreements, and non-employee director compensation Summary of Executive Compensation for 2022 | Name and Principal Position | Salary ($) | Bonus ($) | Stock Awards ($) | Option Awards ($) | All Other Comp ($) | Total ($) | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Anthony Hayes, CEO | 500,000 | 500,000 | 484,888 | - | 208,462 | 1,693,350 | | Darrell Dotson, VP | 317,308 | - | - | - | - | 317,308 | | Christopher Devall, VP of Ops | 125,000 | 100,000 | 47,601 | - | - | 272,601 | | Carlos Aldovero, President | 198,750 | 213,000 | 146,250 | - | 71,589 | 629,589 | - CEO Anthony Hayes's employment agreement provides for a **$500,000 annual salary** and an annual cash bonus of up to **$250,000** based on performance criteria[397](index=397&type=chunk) - Carlos Aldavero's employment agreement includes a base salary of **$450,000 per annum** and a cash signing bonus of **$213,000**[406](index=406&type=chunk) - Non-employee directors receive an annual retainer of **$65,000**, paid in cash, with an additional **$5,000** for the Chairman of the Board[412](index=412&type=chunk) [Security Ownership of Certain Beneficial Owners and Management, and Related Stockholders](index=82&type=section&id=Item%2012.%20Security%20Ownership%20of%20Certain%20Beneficial%20Owners%20and%20Management%2C%20and%20Related%20Stockholders) As of **March 20, 2023**, directors and officers as a group beneficially owned **9.43%** of common stock, with details on individual holdings and preferred stock owners Beneficial Ownership of Common Stock (as of March 20, 2023) | Name of Beneficial Owner | Shares Beneficially Owned | Percentage | | :--- | :--- | :--- | | Anthony Hayes (CEO) | 176,681 | 3.64% | | Kyle Wool (Director) | 197,080 | 4.07% | | All Directors and Officers as a Group (10 persons) | 436,522 | 9.43% | - As of **March 20, 2023**, there were **4,840,597 shares of Common Stock**, **3,825 shares of Series D Preferred Stock**, and **834 shares of Series D-1 Preferred Stock outstanding**[417](index=417&type=chunk) [Certain Relationships and Related Transactions, and Director Independence](index=86&type=section&id=Item%2013.%20Certain%20Relationships%20and%20Related%20Transactions%2C%20and%20Director%20Independence) The Board has a majority of independent directors, and the company engaged Revere Securities, LLC, a firm with ties to a director and the CEO, for investment management - The Board has determined that directors Vander Zanden, Ledwick, Wool, Blattner, and Yu are independent[421](index=421&type=chunk) - The company engaged Revere Securities, LLC, where director Kyle Wool is president, for investment management services, and CEO Anthony Hayes acquired an **8% ownership interest** in Revere[423](index=423&type=chunk) [Principal Accounting Fees and Services](index=86&type=section&id=Item%2014.%20Principal%20Accounting%20Fees%20and%20Services) The company paid **Marcum LLP $91,417** in audit fees for **2022** and **WithumSmith+Brown, PC $41,200** for **2021**, with all services pre-approved by the Audit Committee Auditor Fees | Auditor | Fiscal Year | Audit Fees | | :--- | :--- | :--- | | Marcum LLP | 2022 | $91,417 | | WithumSmith+Brown, PC | 2021 | $41,200 | - The Audit Committee has a policy for pre-approving all audit and permissible non-audit services provided by the principal accountants[427](index=427&type=chunk) Part IV [Exhibits, Consolidated Financial Statements, Schedules](index=88&type=section&id=Item%2015.%20Exhibits%2C%20Consolidated%20Financial%20Statements%2C%20Schedules) This section lists exhibits filed with the Form 10-K, including corporate governance documents, material contracts, and Sarbanes-Oxley Act certifications - This section provides a list of all exhibits filed with the **10-K**, including the Amended and Restated Membership Interest Purchase Agreement for the FPS acquisition[431](index=431&type=chunk)[433](index=433&type=chunk) - Certifications from the Principal Executive Officer pursuant to Sections **302** and **906** of the Sarbanes-Oxley Act of **2002** are included as exhibits[433](index=433&type=chunk) [Form 10-K Summary](index=92&type=section&id=Item%2016.%20Form%2010-K%20Summary) This item is not applicable to the company - This section is not applicable[434](index=434&type=chunk)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number 000-05576 AIKIDO PHARMA INC. (Exact name of registrant as specified in its charter) Delaware 52-0849320 ( ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number 000-05576 | --- | --- | |--------------------------------------------------------------------|---------------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number 000-05576 | --- | --- | |--------------------------------------------|--------------------------------------- ...